- Ipsen announces new data on Dysport in neurological disease
- PMGroup Worldwide Ltd welcomes MAD World Summit
- Argenx receives review from FDA for VYVGART in seronegative gMG
- Nuclera extends Series C funding to advance antibody engineering
- Increasing trial participation for new cancer treatments
- Ontologies – what do they have to do with pharma research?
- Fighting the stigmatization of monkeypox patients
- Mobilizing against monkeypox
- Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report
- Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win
- 'Extreme disappointment': With FDA snub of Akebia's vadadustat, another oral anemia med bites the dust
- Senate blesses bill to wrest US supply chains from China's grasp, with pharma front and center